Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment
In 2011, National Institute on Aging and Alzheimer's Association joint task forces released proposed criteria for Alzheimer' disease diagnosis. These proposals included revisions to the nearly 30-year-old NINDS-ADRDA criteria for Alzheimer's diagnosis and added criteria for diagnosis of Mild Cognitive Impairment (MCI) due to Alzheimer's disease. The same year the American Psychiatric Association proposed new criteria for major and minor neurocognitive disorders (the entities previously known as dementia and mild cognitive impairment, respectively). These new criteria reflect the research and clinical advances in identifying mild cognitive impairment and offer new opportunities for prevention, treatment, and management of neurodegenerative conditions.
1113119062
Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment
In 2011, National Institute on Aging and Alzheimer's Association joint task forces released proposed criteria for Alzheimer' disease diagnosis. These proposals included revisions to the nearly 30-year-old NINDS-ADRDA criteria for Alzheimer's diagnosis and added criteria for diagnosis of Mild Cognitive Impairment (MCI) due to Alzheimer's disease. The same year the American Psychiatric Association proposed new criteria for major and minor neurocognitive disorders (the entities previously known as dementia and mild cognitive impairment, respectively). These new criteria reflect the research and clinical advances in identifying mild cognitive impairment and offer new opportunities for prevention, treatment, and management of neurodegenerative conditions.
65.0 Out Of Stock
Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment

Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment

Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment

Mild Cognitive Impairment and Dementia: Definitions, Diagnosis, and Treatment

Paperback

$65.00 
  • SHIP THIS ITEM
    Temporarily Out of Stock Online
  • PICK UP IN STORE

    Your local store may have stock of this item.

Related collections and offers


Overview

In 2011, National Institute on Aging and Alzheimer's Association joint task forces released proposed criteria for Alzheimer' disease diagnosis. These proposals included revisions to the nearly 30-year-old NINDS-ADRDA criteria for Alzheimer's diagnosis and added criteria for diagnosis of Mild Cognitive Impairment (MCI) due to Alzheimer's disease. The same year the American Psychiatric Association proposed new criteria for major and minor neurocognitive disorders (the entities previously known as dementia and mild cognitive impairment, respectively). These new criteria reflect the research and clinical advances in identifying mild cognitive impairment and offer new opportunities for prevention, treatment, and management of neurodegenerative conditions.

Product Details

ISBN-13: 9780199764181
Publisher: Oxford University Press, USA
Publication date: 02/28/2013
Series: AACN Workshop Series
Pages: 416
Product dimensions: 6.10(w) x 9.20(h) x 1.20(d)

About the Author

Glenn E. Smith, Ph.D., ABPP/CN, is a board-certified clinical neuropsychologist and Professor of Psychology at Mayo Clinic in Rochester MN. He has served as principal investigator of the Mayo Alzheimer's Disease Research Center Education Core and is Associate Director of Mayo's Clinical and Translational Science Education Resource. Dr. Smith has had continuous research funding since 1994 and has authored or co-authored over 180 original articles on normal aging, mild cognitive impairment, and dementia. He is past president of the American Board of Clinical Neuropsychology and of the Division of Clinical Neuropsychology of the American Psychological Association. In addition to supervising post-doctoral fellows, he maintains an active diagnostic neuropsychology practice. He led development of and directs Mayo's Dementia Behavior Assessment and Response Team and HABIT (Healthy Action to Benefit Independence and Thinking) program for persons with Mild Cognitive Impairment.

Mark W. Bondi, Ph.D., ABPP/CN, is a board-certified clinical neuropsychologist, Professor of Psychiatry at the University of California San Diego, and Director of the Neuropsychological Assessment Unit at the VA San Diego Healthcare System. He is recipient of a Mid-Career Investigator Award in Patient-Oriented Research from the National Institute on Aging. His NIH funded research centers on the cognitive and brain changes of individuals at risk for dementia, and he has published more than 120 articles, books, and book chapters. Dr. Bondi is a Fellow of the American Psychological Association and National Academy of Neuropsychology, former Secretary APA's Division of Clinical Neuropsychology, and serves on the Board of Directors of the American Board of Clinical Neuropsychology and Board of Governors of the International Neuropsychological Society. Dr. Bondi maintains a clinical practice in neuropsychology, and he is an active teacher and supervisor for his institution's doctoral training, predoctoral internship, and postdoctoral fellowship programs.

Table of Contents

Chapter 1: Introduction
Chapter 2: Role of Neuropsychological Measurement in MCI and Dementia Assessment
Chapter 3: Normal Cognitive Aging
Chapter 4: Mild Cognitive Impairment
Chapter 5: Alzheimer's Disease
Chapter 6: Vascular Dementia
Chapter 7: Dementia with Lewy Bodies (With Guest Author Tanis J Ferman, PhD)
Chapter 8: Frontotemporal Dementias
Chapter 9: Atypical Dementias (With David P. Salmon, Ph.D.)
Chapter 10: Interventions for the Behavioral Disturbances of Dementia

From the B&N Reads Blog

Customer Reviews